Special Issues

Special Issues

We bring you special features throughout the year to enhance the depth of our hematology and oncology coverage

May 2017 Special Edition

This special edition features updates in the world of myeloid malignancies, including a review of investigational treatment options and news from recent hematologic conferences.

Focus on Rare Diseases (October 2016, Volume 2, Issue 10.1)

This supplement features FDA updates, clinical trials, policy updates, and the latest research in hematologic rare diseases.

Focus on Trainees & Fellows (September 2016, Volume 2, Issue 9.1)

This special edition features advice and resources for trainees and fellows.

Hematology Pipeline Update (February 2016, Volume 2, Issue 2.1)

This supplement features updated information on late-breaking drug approvals for bleeding disorders, leukemia, and myeloma.

Advances in Hematology Research & Patient Care (January 2016, Volume 2, Issue 1.1)

This special edition takes a deep dive into coverage from the 2015 ASH Annual Meeting, including interviews with speakers and up-to-date clinical findings presented at the meeting.

Focus on Myeloma (October 2015, Volume 1, Issue 10.1)

This special issue of ASH Clinical News features updates in the world of multiple myeloma, including treatment options, advancements in understanding the disease, and looking ahead to the landscape of care.

Hematology Pipeline Update (February 2015, Volume 1, Issue 2.1)

A special edition featuring drug updates from the 2014 ASH Annual Meeting.
Advertisement

Current Issue

May 2017, Volume 3, Issue 6

This issue discusses the legacy of Agent Orange and hematologic malignancies, a debate over transplant in myelodysplastic syndromes, and more.